Toyama, Japan

Masayasu Fukagawa

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayasu Fukagawa. Retrieved from https://idiyas.com/inventor/masayasu-fukagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Masayasu Fukagawa

Introduction

Masayasu Fukagawa is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinazoline derivatives. His work has been recognized through his patent, which showcases his innovative approach to drug development.

Latest Patents

Masayasu Fukagawa holds a patent for a "Process for producing quinazoline derivatives." This patent highlights his expertise in creating compounds that have potential therapeutic applications. He has 1 patent to his name, reflecting his focused contributions to the pharmaceutical industry.

Career Highlights

Fukagawa is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his impact on pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Hiroki Omori and Shunsuke Goto. Their collaborative efforts contribute to the innovative environment at Fujisawa Pharmaceutical Company, Ltd., fostering advancements in drug development.

Conclusion

Masayasu Fukagawa's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of quinazoline derivatives, demonstrate his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…